← All companies
OFIX
Orthofix Medical Inc.
$12.26
+0.47 +3.99%
Key statistics
from XBRL data in SEC filingsMarket cap
$496M
Revenue (TTM)
$825M
Net income (TTM)
-$60.0M
EPS (TTM)
$-1.50
P/E ratio
—
Dividend yield
—
Free cash flow
-$1.28M
Cash
$120M
Total assets
$887M
Gross margin
70.7%
52-week range
$8.85 – $16.99
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 2, 2026
8-K
Director or officer change; Shareholder vote results
Jun 11, 2026
8-K
Regulation FD disclosure
May 21, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 5, 2026
8-K
Results of operations (earnings release); Director or officer change
Apr 9, 2026
10-K
Fiscal year ended 2025-12-31
Feb 24, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 24, 2026
10-Q
Quarter ended 2025-09-30
Nov 4, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 4, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 5, 2025
8-K
Shareholder vote results
Jun 20, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 6, 2025
8-K
Entered a material agreement; Terminated a material agreement
Apr 7, 2025
8-K
Director or officer change; Regulation FD disclosure
Mar 12, 2025
10-K
Fiscal year ended 2024-12-31
Feb 25, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 25, 2025
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation
Nov 8, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 7, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 6, 2024
8-K
Director or officer change; Shareholder vote results
Jun 20, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2024
8-K
Entered a material agreement
Apr 22, 2024
8-K
Director or officer change
Apr 12, 2024
10-K
Fiscal year ended 2023-12-31
Mar 5, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 5, 2024
8-K
Director or officer change; Regulation FD disclosure
Jan 17, 2024
8-K
Results of operations (earnings release); Director or officer change
Jan 9, 2024
8-K
Regulation FD disclosure
Jan 8, 2024
8-K
Entered a material agreement; Director or officer change; Other events
Dec 15, 2023
8-K
Director or officer change; Regulation FD disclosure
Dec 1, 2023
10-Q
Quarter ended 2023-09-30
Nov 8, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 8, 2023
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation
Nov 8, 2023
8-K
Director or officer change
Oct 5, 2023